Advisors Asset Management Inc. boosted its stake in Intrexon Corp. (NYSE:XON) by 3.6% during the second quarter, Holdings Channel reports. The fund owned 31,415 shares of the company’s stock after buying an additional 1,091 shares during the period. Advisors Asset Management Inc.’s holdings in Intrexon Corp. were worth $773,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of XON. BlackRock Institutional Trust Company N.A. increased its position in shares of Intrexon Corp. by 1.0% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 1,195,625 shares of the company’s stock valued at $40,520,000 after buying an additional 12,081 shares during the last quarter. Norges Bank purchased a new position in shares of Intrexon Corp. during the fourth quarter valued at approximately $12,584,000. First Trust Advisors LP increased its position in shares of Intrexon Corp. by 412.5% in the second quarter. First Trust Advisors LP now owns 320,868 shares of the company’s stock valued at $7,897,000 after buying an additional 258,257 shares during the last quarter. Bank of New York Mellon Corp purchased a new position in shares of Intrexon Corp. during the second quarter valued at approximately $5,312,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Intrexon Corp. by 3.1% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 146,537 shares of the company’s stock valued at $3,606,000 after buying an additional 4,360 shares during the last quarter. 84.05% of the stock is currently owned by institutional investors.

Shares of Intrexon Corp. (NYSE:XON) traded down 1.60% during trading on Friday, reaching $27.59. 451,027 shares of the company were exchanged. Intrexon Corp. has a 1-year low of $18.52 and a 1-year high of $45.90. The firm’s market capitalization is $3.26 billion. The firm’s 50 day moving average is $27.36 and its 200 day moving average is $28.74.

Intrexon Corp. (NYSE:XON) last issued its quarterly earnings results on Tuesday, August 9th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.26) by $0.16. The company earned $52.50 million during the quarter, compared to the consensus estimate of $53.78 million. Intrexon Corp. had a negative return on equity of 19.00% and a negative net margin of 96.65%. The firm’s quarterly revenue was up 17.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.37) earnings per share. On average, equities analysts anticipate that Intrexon Corp. will post ($1.36) EPS for the current fiscal year.

A number of research analysts have issued reports on the stock. Vetr raised shares of Intrexon Corp. from a “strong sell” rating to a “buy” rating and set a $27.01 price objective on the stock in a research report on Thursday, July 28th. Griffin Securities reissued a “buy” rating and set a $55.00 price objective on shares of Intrexon Corp. in a research report on Tuesday, August 16th. JMP Securities reissued a “buy” rating on shares of Intrexon Corp. in a research report on Sunday, July 17th. Zacks Investment Research downgraded shares of Intrexon Corp. from a “buy” rating to a “hold” rating in a research report on Friday, August 12th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $57.00 price objective on shares of Intrexon Corp. in a research report on Wednesday, June 29th. Three equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Intrexon Corp. has an average rating of “Buy” and a consensus target price of $41.71.

In related news, SVP Nir Nimrodi purchased 4,000 shares of the stock in a transaction that occurred on Monday, August 29th. The stock was bought at an average cost of $26.12 per share, for a total transaction of $104,480.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 55.10% of the stock is owned by corporate insiders.

Intrexon Corp. Company Profile

Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company’s synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale.

5 Day Chart for NYSE:XON

Want to see what other hedge funds are holding XON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intrexon Corp. (NYSE:XON).

Receive News & Ratings for Intrexon Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corp. and related companies with MarketBeat.com's FREE daily email newsletter.